![]() ![]() Argenx has a string of drugs, based on this and other formulae, in the pipeline, including several that are close to the approval stage. The drug is based on an antibody fragment called efgartigimod, which the company is investigating for use against other diseases. ![]() This is a rare and chronic autoimmune disease that causes debilitating and sometimes life-threatening muscle weakness. The company has one approved drug, Vyvgart, a prescription medicine designed for adults with generalised myasthenia gravis. Source: Citywire/Morningstar, latest disclosed holdings data ![]() Simon Webber, Tom Coutts and Lawrence Burns That comfortably earns it a Tier One Citywire company rating. The high levels of conviction being shown towards the shares by these managers place Argenx at 15th place in Fix the Future’s league table based on conviction, which contains a total of more than 5,000 companies. The shares are owned by 18 of the world’s best-performing investors tracked by Citywire Fix the Future, suggesting its chances of success are better than most. Into this sea of possible troubles comes Argenx, a Dutch-headquartered biopharmaceutical company that specialises in treatments for people suffering from severe autoimmune diseases. Pick a winner, though, and the risk is worth it, as the revenues pour in and the treatment becomes a household name. On the face of it, they look like risky bets. They are often loss-making, with sometimes little prospect of profitability in immediate sight. At the same time, their therapies can be unproven, with the implicit chance they might fail, even in late-stage trials.īiotechs famously burn through cash as they invest in research, development and trials, only to then throw money at marketing once their drug is given the regulatory green light and ready for launch. Biotechnology companies are often cutting-edge leaders in their field, pioneering landmark clinical and medical breakthroughs and developing potentially lifesaving treatments for diseases from cancer to obesity. ![]() If you are critical-thinker who enjoys learning, isn't afraid of new challenges, and would like to find a long-term employment home with opportunities to excel – not just punch keys, this is your opportunity!Įnsure Compliance with Company Policy, HIPAA, & Insurance GuidelinesĮducation: High school diploma or GED required.Įxcellent verbal and written communication skills required.Ĭandidates with prior work experience at a Durable/Home Medical Equipment (DME/HME) supplier, hospital, home health, physician's office, or other medical entity are preferred.Ĭandidates who possess a working knowledge of medical terminology, medical billing practices, medical coding systems (CPT, ICD, HCPC, etc.), and modifiers are preferred.įlexibility and strong organizational skills needed.LONDON: It can feel like the most treacherous of sectors, even for the smartest investor. We offer health, dental, and vision insurance, 401K (with employer contributions), flexible scheduling, and paid time off. Using Argencis Medical's operating system, a solid understanding of billing and coding practices, and a Team approach, Medical Billing & Customer Service Representatives enter patient data, verify insurance benefits, review compliance guidelines, create supply orders, file claims, and pursue reimbursement. Medical Billing Job description Medical Billing Specialists at Argencis Medical enjoy a dynamic work environment and a family-friendly atmosphere at its modern, newly remodeled company headquarters conveniently located in the heart of downtown Oklahoma City. ![]()
0 Comments
Leave a Reply. |